The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchA joint that turns hot, red and swollen.
How Cartalax works
Khavinson tripeptide bioregulator for cartilage and connective tissue — proposed to act on gene expression in chondrocytes and mesenchymal stem cells.
Ala-Glu-Asp-Gly — a defined tetrapeptide targeting connective and vascular tissue, proposed to normalize gene expression in vessel walls and cartilage matrix.
- Injectable
Research on Cartalax5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Used for joint and connective tissue support, often in courses alongside Sigumir. Reported experience is slow and modest, and hard to separate from the natural fluctuation of joint symptoms.
How the mechanism reads
Ala-Glu-Asp-Gly — a defined tetrapeptide targeting connective and vascular tissue, proposed to normalize gene expression in vessel walls and cartilage matrix.
MechanisticThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticCartilage is the hardest tissue in the body to affect from the outside — it is avascular, so anything systemic has to diffuse in through synovial fluid. That is a real pharmacokinetic obstacle nobody in this series has addressed.
Mechanistic
Sources
- Linkova N, Khavinson V, Diatlova A, Myakisheva S, Ryzhak G. Peptide Regulation of Chondrogenic Stem Cell Differentiation. International Journal of Molecular Sciences 2023;24(9):8415 · PMID 37176122
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Khavinson VKh. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine 2012 · PMID 22808515
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
Cartalax safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- A hot, swollen, painful joint with fever, which can be infection.
- Inflammatory arthritis that is still being diagnosed.
- Active cancer, as the peptides claim to steer stem-cell differentiation.
- Pregnancy, since cartilage and mesenchymal pathways are active in fetal development.
What’s expected
- Nothing immediate; chondrocyte gene-expression effects are claimed over weeks.
- Mild injection-site soreness.
- Evidence is cell culture and small Russian series.
Watch for
- A joint that turns hot, red and swollen.
- Night pain that is getting worse.
- Morning stiffness lasting over an hour.
Labs that tell you it’s working
- hs-CRP: an inflammatory flare would raise it independent of the peptide.
- ESR: a slower inflammation marker for arthritic disease.
- Uric Acid: separates gout from cartilage wear.
- Rheumatoid Factor: flags an inflammatory arthritis that cartilage peptides cannot fix.
Ala-Glu-Asp tripeptide bioregulator proposed to act on chondrocyte and mesenchymal stem cell gene expression; main risk is missing joint disease. PMID 37176122
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Cartalax FAQ4 common questions
- Is Cartalax approved for human use?
- No. Cartalax is a research compound.
- What is Cartalax researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- hs-CRP; ESR; Uric Acid; Rheumatoid Factor: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Cartalax: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




